Kostas Biliouris
Stock Analyst at Oppenheimer
(0.66)
# 4,196
Out of 5,043 analysts
442
Total ratings
37.9%
Success rate
-1.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kostas Biliouris
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEPG PepGen | Reiterated: Buy | $15 | $2.40 | +525.00% | 4 | Oct 8, 2026 | |
| KRRO Korro Bio | Reiterated: Buy | $22 | $10.48 | +109.92% | 19 | Oct 6, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | $11 | $3.90 | +182.05% | 20 | Sep 25, 2026 | |
| EVMN Evommune | Reiterated: Buy | $50 → $26 | $6.22 | +318.01% | 4 | Sep 9, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $10 → $20 | $4.41 | +353.51% | 3 | Sep 9, 2026 | |
| TRDA Entrada Therapeutics | Reiterated: Buy | $23 | $5.61 | +309.98% | 5 | Sep 3, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | $9 | $2.36 | +281.36% | 2 | Aug 14, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $9 | $1.63 | +452.15% | 4 | Aug 14, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $56.88 | $11.13 | +411.03% | 3 | Aug 14, 2026 | |
| LEGN Legend Biotech | Downgraded: Hold | $75 → $40 | $19.12 | +109.21% | 60 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $35 | $17.50 | +100.00% | 38 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 → $350 | $224.41 | +55.96% | 41 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $22.73 | +23.19% | 2 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $11.69 | +79.64% | 4 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $6.25 | +220.00% | 21 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $66.50 | n/a | 12 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $24.77 | n/a | 23 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $55.20 | n/a | 31 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.97 | n/a | 5 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.59 | n/a | 30 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $44.16 | n/a | 27 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5697 | n/a | 4 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9847 | n/a | 9 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.71 | n/a | 25 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.54 | n/a | 5 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.82 | n/a | 14 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $52.35 | n/a | 20 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.62 | n/a | 6 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $77 | $293.26 | n/a | 1 | Jun 16, 2022 |
PepGen
Oct 8, 2026
Reiterated: Buy
Price Target: $15
Current: $2.40
Upside: +525.00%
Korro Bio
Oct 6, 2026
Reiterated: Buy
Price Target: $22
Current: $10.48
Upside: +109.92%
Prime Medicine
Sep 25, 2026
Reiterated: Buy
Price Target: $11
Current: $3.90
Upside: +182.05%
Evommune
Sep 9, 2026
Reiterated: Buy
Price Target: $50 → $26
Current: $6.22
Upside: +318.01%
Opus Genetics
Sep 9, 2026
Reiterated: Buy
Price Target: $10 → $20
Current: $4.41
Upside: +353.51%
Entrada Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $23
Current: $5.61
Upside: +309.98%
Ovid Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $9
Current: $2.36
Upside: +281.36%
ProQR Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $9
Current: $1.63
Upside: +452.15%
Satellos Bioscience Inc.
Aug 14, 2026
Reiterated: Buy
Price Target: $56.88
Current: $11.13
Upside: +411.03%
Legend Biotech
Aug 12, 2026
Downgraded: Hold
Price Target: $75 → $40
Current: $19.12
Upside: +109.21%
Aug 6, 2026
Reiterated: Buy
Price Target: $37 → $35
Current: $17.50
Upside: +100.00%
Jul 31, 2026
Reiterated: Buy
Price Target: $500 → $350
Current: $224.41
Upside: +55.96%
Jul 10, 2026
Reiterated: Buy
Price Target: $28
Current: $22.73
Upside: +23.19%
Jun 15, 2026
Reiterated: Buy
Price Target: $21
Current: $11.69
Upside: +79.64%
Jun 9, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $6.25
Upside: +220.00%
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $66.50
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $24.77
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $55.20
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $15.97
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $12.59
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $44.16
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $0.5697
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $0.9847
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $11.71
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $2.54
Upside: n/a
Sep 25, 2025
Rated: Hold
Price Target: n/a
Current: $9.82
Upside: n/a
Sep 23, 2025
Reiterated: Buy
Price Target: $75
Current: $52.35
Upside: n/a
Jan 29, 2024
Rated: Hold
Price Target: n/a
Current: $3.62
Upside: n/a
Jun 16, 2022
Initiated Coverage: Buy
Price Target: $77
Current: $293.26
Upside: n/a